Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains

Emerging Microbes and Infections

Volumn 4, Issue 1, 2015, Pages e1-

  Liu, Huayong ^a   Zhao, Yanfeng ^b   Zhao, Dan ^c   Gong, Ting ^a   Wu, Youcong ^a   Han, Haiyan ^a   Xu, Tao ^a   Peschel, Andreas ^d   Han, Shiqing ^c   Qu, Di ^a  

^a FUDAN UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c NANJING TECH UNIVERSITY   (China)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anti biofilm activity; Antibacterial; Methicillin resistant Staphylococcus aureus; MIC05; Minimal inhibitory concentration; Staphylococcus epidermidis

Indexed keywords

THIAZOLIDINE DERIVATIVE; ANTIINFECTIVE AGENT; THIAZOLE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOFILM ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; THICKNESS; CHEMISTRY; CHINA; CONFOCAL MICROSCOPY; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; PHYSIOLOGY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; TERTIARY CARE CENTER;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BIOFILMS; CHINA; HOSPITALS, TEACHING; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TERTIARY CARE CENTERS; THIAZOLES;

EID: 84931271358     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2015.1     Document Type: Article

References (37)

1. Manunga J Jr, Olak J, Rivera C, Martin M. Prevalence of methicillin-resistant Staphylococcus aureus in elective surgical patients at a public teaching hospital: an analysis of 1039 patients. Am Surg 2012; 78: 1096-1099.
2. Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002; 78: 385-392.
3. Morell EA, Balkin DM. Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. Yale J Biol Med 2010; 83: 223-233.
4. Kateete DP, Namazzi S, Okee M et al. High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda. BMC Res Notes 2011; 4: 326.
5. Haaber J, Cohn MT, Frees D, Andersen TJ, Ingmer H. Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. PloS One 2012; 7: e41075.
6. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med 2013; 64: 175-188.
7. Cue D, Lei MG, Lee CY. Genetic regulation of the intercellular adhesion locus in staphylococci. Front Cell Infect Microbiol 2012; 2: 38.
8. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-39.
9. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001; 45:999-1007.
10. Hou W, Sun X, Wang Z, Zhang Y. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections. Invest Ophthalmol Vis Sci 2012; 53: 5624-5631.
11. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-1429.
12. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47: 317-323.
13. Aendekerk S, Diggle SP, Song Z et al. The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 2005; 151(Pt 4): 1113-1125.
14. Dubrac S, Msadek T. Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system. Adv Exp Med Biol 2008; 631: 214-228.
15. Dubrac S, Bisicchia P, Devine KM, Msadek T. A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol Microbiol 2008; 70: 1307-1322.
16. Okada A, Igarashi M, Okajima T et al. Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth. J Antibiot 2010; 63: 89-94.
17. Watanabe T, Hashimoto Y, Yamamoto K et al. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus. J Antibiot 2003; 56: 1045-1052.
18. Yamamoto K, Kitayama T, Minagawa S et al. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. BiosciBiotechnolBiochem2001; 65: 2306-2310.
19. Hilliard JJ, Goldschmidt RM, Licata L, Baum EZ, Bush K. Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother 1999; 43: 1693-1699.
20. Qin Z, ZhangJ, Xu B et al. Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiol 2006; 6: 96.
21. Huang RZ, Zheng LK, Liu HY et al. Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis. Acta Pharmacol Sin 2012; 33: 418-425.
22. Pan B, Huang R, Zheng L et al. Thiazolidione derivatives as novel antibiofilm agents: design, synthesis, biologicalevaluation, and structure-activity relationships. Eur J Med Chem 2011; 46: 819-824.
23. Liu H, Zhao D, Chang J et al. Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein. Appl Microbiol Biotechnol 2014; 98: 6003-6013.
24. Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother 2012; 56: 1324-1330.
25. O'Neill E, Pozzi C, Houston P et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol 2007; 45: 1379-1388.
26. Stepanovic S, Vukovic D, Hola V et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007; 115: 891-899.
27. Jiang L, Wang F, Han F, Prinyawiwatkul W, No HK, Ge B. Evaluation of diffusion and dilution methods to determine the antimicrobial activity of water-soluble chitosan derivatives. J Appl Microbiol 2013; 114: 956-963.
28. Peterson JF, Pfaller MA, Diekema DJ, Rinaldi MG, Riebe KM, Ledeboer NA. Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. J Clin Microbiol 2011; 49: 1765-1771.
29. Ning Y, Hu X, Ling J et al. Candida albicans survival and biofilm formation under starvation conditions. Int Endod J 2013; 46: 62-70.
30. Liduma I, Tracevska T, Bers U, Zilevica A. Phenotypic and genetic analysis of biofilm formation by Staphylococcus epidermidis. Medicina (Kaunas) 2012; 48: 305-309.
31. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 2002; 66: 86-92.
32. Saginur R, Stdenis M, Ferris W et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006; 50: 55-61.
33. Elhani D. [Does the emergence of antibiotic resistance announce the return of the dark ages?] Ann Biol Clin (Paris) 2011; 69: 637-646. French.
34. Woodford N, Wareham DW; UK Antibacterial Antisense Study Group. Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother 2009; 63: 225-229.
35. Dubrac S, Boneca IG, Poupel O, Msadek T. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J Bacteriol 2007; 189: 8257-8269.
36. Monzon M, Oteiza C, Leiva J, Amorena B. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2001; 48: 793-801.
37. Kiedrowski MR, Horswill AR. New approaches for treating staphylococcal biofilm infections. Ann NY Acad Sci 2011; 1241: 104-121.